Abstract
Stem cell therapeutics is the future of regenerative medicine in the modern world. Many studies have been instigated with the hope of translating the outcome for the treatment of several disease conditions ranging from heart and neuronal disease to malignancies as grave as cancers. Stem cell therapeutics undoubtedly holds great promise on the front of regenerative medicine, however, the correct distribution and homing of these stem cells to the host site remained blinded until the recent advances in the discipline of molecular imaging. Herein, we discuss the various imaging guidance applied for determination of the proper delivery of various types of stem cell used as therapeutics for various maladies. Additionally, we scrutinize the use of several indirect labeling mechanisms for efficient tagging of the reporter entity for image guidance. Further, the promise of improving patient healthcare has led to the initiation of several clinical trials worldwide. However, in number of the cases, the benefits arrive with a price heavy enough to pose a serious health risk, one such being formation of teratomas. Thus numerous challenges and methodological obstacles must be overcome before their eloquent clinical impact can be realized. Therefore, we also discuss several clinical trials that have taken into consideration the various imaging guided protocols to monitor correct delivery and understand the distribution of therapeutic stem cells in real time.
Keywords: Molecular imaging, regenerative medicine, stem cells, stem cell tracking, therapeutics.
Current Drug Targets
Title:Image Guidance in Stem Cell Therapeutics: Unfolding the Blindfold
Volume: 16 Issue: 6
Author(s): Amirali B. Bukhari, Shruti Dutta and Abhijit De
Affiliation:
Keywords: Molecular imaging, regenerative medicine, stem cells, stem cell tracking, therapeutics.
Abstract: Stem cell therapeutics is the future of regenerative medicine in the modern world. Many studies have been instigated with the hope of translating the outcome for the treatment of several disease conditions ranging from heart and neuronal disease to malignancies as grave as cancers. Stem cell therapeutics undoubtedly holds great promise on the front of regenerative medicine, however, the correct distribution and homing of these stem cells to the host site remained blinded until the recent advances in the discipline of molecular imaging. Herein, we discuss the various imaging guidance applied for determination of the proper delivery of various types of stem cell used as therapeutics for various maladies. Additionally, we scrutinize the use of several indirect labeling mechanisms for efficient tagging of the reporter entity for image guidance. Further, the promise of improving patient healthcare has led to the initiation of several clinical trials worldwide. However, in number of the cases, the benefits arrive with a price heavy enough to pose a serious health risk, one such being formation of teratomas. Thus numerous challenges and methodological obstacles must be overcome before their eloquent clinical impact can be realized. Therefore, we also discuss several clinical trials that have taken into consideration the various imaging guided protocols to monitor correct delivery and understand the distribution of therapeutic stem cells in real time.
Export Options
About this article
Cite this article as:
Bukhari B. Amirali, Dutta Shruti and De Abhijit, Image Guidance in Stem Cell Therapeutics: Unfolding the Blindfold, Current Drug Targets 2015; 16 (6) . https://dx.doi.org/10.2174/1389450116666141205162939
DOI https://dx.doi.org/10.2174/1389450116666141205162939 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Chronic Heart Failure and Comorbid Renal Dysfunction - A Focus on Type 2 Cardiorenal Syndrome
Current Cardiology Reviews Epidemiology and Natural History of Patients with NAFLD
Current Pharmaceutical Design Insulin Resistance, Obesity and the Metabolic Syndrome. Is there a Therapeutic Role for Endothelin-1 Antagonists?
Current Vascular Pharmacology Seaweed Proteins as a Source of Bioactive Peptides
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Cardiology Reviews New Therapeutic Strategies in Perinatal Stroke
Current Drug Targets - CNS & Neurological Disorders Animal Models to Study Plaque Vulnerability
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Neuropharmacology Metabolic Ataxias in Adults
Current Molecular Medicine Extracellular Vesicles as Drug Delivery Vehicles for Rheumatoid Arthritis
Current Stem Cell Research & Therapy Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Editorial (Hot Topic: Platelets in Vascular Homeostasis and Inflammation: Current Perspectives from Bench to Bedside)
Current Vascular Pharmacology Triple Therapy Versus Dual Antiplatelet Therapy for Patients with Atrial Fibrillation and Acute Coronary Syndromes: A Systematic Literature Review
Current Cardiology Reviews The Role of Minocycline in Ischemia-Reperfusion Injury: A Comprehensive Review of an Old Drug with New Implications
Recent Patents on Cardiovascular Drug Discovery Meet Our Editorial Board Member
Current Cardiology Reviews The Possible Regulatory Mechanisms of Aqueous, Ethyl Acetate and NHexane Fractions of the <i>Ribes khorassanicum</i> Extract on Acute Hypertension in Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Acute Kidney Injury after Complex Endovascular Aneurysm Repair
Current Pharmaceutical Design TRP Channels: Emerging Links Between Ca2+, Kidney and Hypertension
Current Hypertension Reviews A Review of Theranostics Applications and Toxicities of Carbon Nanomaterials
Current Drug Metabolism Intraventricular Recombinant Tissue Plasminogen Activator in Treatment of Aneurysmal Intraventricular Hemorrhage: A Meta-Analysis
Current Drug Targets